Since June 2018, Guenter Huhle has been responsible for setting the strategic direction and overseeing all operational activities for JLABS in Europe, including managing JLABS @ BE. In conjunction with his EMEA Innovation Centre colleagues and his sector business partners, Guenter is in charge of creating strategic partnerships with corporate, academic, government and industry organizations to build a strong and dynamic network of innovation for patients and consumers.
Prior to joining JLABS, Guenter was leading the Business Development Organization and the Mature Brands at Janssen – the pharmaceutical companies of Johnson & Johnson in EMEA (Europe Middle East and Africa incl. Russia and CIS). Guenter received his MD and PhD from the University of Heidelberg and his Master of Science from the University of Witten/Herdecke. He is board accredited in Internal Medicine and Haemostaseology and has a Professorship at the University of Heidelberg. Since Guenter moved into the pharmaceutical Industry in 2001, he has held various national, regional and global leadership positions in R&D, Medical and the Business, first at Eli Lilly and then at Merck KGaA until joining Janssen and Johnson & Johnson in 2007. Guenter is experienced in Business Modeling, Licensing, Merger & Acquisitions, and Market Access in Healthcare.
Guenter privately supports startup businesses as an investor and entrepreneur and founded Corevas® in 2015. Corevas® is a privately owned limited liability company developing EmergencyEye®, a potentially life-saving communication technology innovation for emergency case management launched at the end of 2018.
November 13, 2019
The Innovation Lab
- The Innovation Lab
This stream will focus on bringing the Lab of the Future to life. Enabling collaborations and partnerships, running innovation hubs and creating the physical and business environments for innovation
- 2:50 pmSolid v Virtual Incubation Labs; Deploying a curated platform to speed innovation